Literature DB >> 9317144

Influenza infection of beta 2-microglobulin-deficient (beta 2m-/-) mice reveals a loss of CD4+ T cell functions with aging.

S F Taylor1, R J Cottey, D S Zander, B S Bender.   

Abstract

Following influenza infection, aged mice have prolonged viral shedding that is presumably due to lower anti-influenza class I-restricted CD8+ CTL activity. To examine alternative viral clearance mechanisms in immunosenescense, we infected young (1.5-2.5 month) and aged (15-18 month) class I and CD8+-deficient beta 2m-/- mice with influenza A/Port Chalmers/1/73 (H3N2). We found that 40% of young beta 2m-/- mice were shedding virus from the lung on day 9 (mean titer of 0.3 log10 TCID[50]), with a maximal anti-influenza class II CTL activity of 68+/-2% on day 7. In contrast, 100% of aged beta 2m-/- mice were still shedding virus (mean titer of 3.0 log10 TCID[50]) from the lung on day 9 with a peak CTL activity of 15+/-6%. Aged beta 2m-/- mice also had significantly lower pulmonary IFN-gamma levels, serum anti-influenza neutralizing Ab, and anti-influenza mucosal IgA titers, as well as a less intense pulmonary inflammatory response on early days of infection. Th2-mediated cytokines were dysregulated. We conclude that there are multiple mechanisms responsible for the age-related delay in recovery from influenza. These include decreased anti-influenza class II-restricted CTL activity, pulmonary IFN-gamma levels, and serum neutralizing Ab. Taken together, these findings show a loss of CD4+ T cell functions with aging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus.

Authors:  S N Han; D Wu; W K Ha; A Beharka; D E Smith; B S Bender; S N Meydani
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

3.  Decreased immune responses to influenza vaccination in patients with heart failure.

Authors:  Orly Vardeny; Nancy K Sweitzer; Michelle A Detry; John M Moran; Maryl R Johnson; Mary S Hayney
Journal:  J Card Fail       Date:  2008-12-18       Impact factor: 5.712

4.  Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.

Authors:  Shu-Ting Ren; Xue-Mei Zhang; Peng-Fei Sun; Li-Juan Sun; Xue Guo; Tian Tian; Jian Zhang; Qi-Yuan Guo; Xue Li; Li-Jun Guo; Jin Che; Bing Wang; Hui Zhang
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 5.  Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.

Authors:  Shahzma Merani; Graham Pawelec; George A Kuchel; Janet E McElhaney
Journal:  Front Immunol       Date:  2017-07-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.